Entrada Therapeutics Inc (TRDA) — Free Cash Flow Generation Index
Entrada Therapeutics Inc (TRDA) has a Free Cash Flow Generation Index of 0.97x as of June 2024. Free cash flow of $38.79 Million represents 1% of operating cash flow ($39.83 Million). Read TRDA total debt and obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Entrada Therapeutics Inc Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Entrada Therapeutics Inc across 1 annual periods. Explore TRDA capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Entrada Therapeutics Inc (2023–2023)
Year-by-year Free Cash Flow Generation Index for Entrada Therapeutics Inc. For the full company profile including market capitalisation, see TRDA company net worth.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.96x | $134.19 Million | $139.80 Million | $5.61 Million | — |